The Library
The association between ANKH promoter polymorphism and chondrocalcinosis is independent of age and osteoarthritis : results of a case–control study
Tools
Tools
Tools
Abhishek, Abhishek, Doherty, Sally A., Maciewicz, Rose A., Muir, Kenneth, Zhang, Weiya, Doherty, Michael and Valdes, Ana M. (2014) The association between ANKH promoter polymorphism and chondrocalcinosis is independent of age and osteoarthritis : results of a case–control study. Arthritis Research & Therapy, 16 (1). R25. doi:10.1186/ar4453
|
PDF
WRAP_Muir_art%3A10.1186%2Far4453.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution 2.0.. Download (618Kb) | Preview |
Official URL: http://dx.doi.org/10.1186/ar4453
Abstract
Introduction: Chondrocalcinosis (CC) most commonly results from calcium pyrophosphate crystal deposition (CPPD). The objective of this study is to examine the association between candidate single-nucleotide polymorphisms (SNPs) and radiographic CC.
Methods: SNPs in ankylosis human (ANKH), high ferritin (HFE), tissue non-specific alkaline phosphatase (TNAP), ecto-neucleotide pyrophosphatase 1 (ENPP1), and transferrin (TE) genes were genotyped in participants of the Genetics of Osteoarthritis and Lifestyle (GOAL) and Nottingham Osteoarthritis Case-Control studies. Adjusted genotype odds ratio (aORGENOTYPE), the OR for association between one additional minor allele and CC, was calculated and adjusted for age, gender, body mass index (BMI), and osteoarthritis (OA) by using binary logistic regression. Statistical significance was set at P ≤0.003 after Bonferroni correction for multiple tests.
Results: The -4bpG > A polymorphism in the 5′ untranslated region (5′ UTR) of ANKH associated with CC after Bonferroni correction. This was independent of age, gender, OA, and BMI; aORGENOTYPE (95% confidence interval, or CI) was 1.39(1.14-1.69) (P = 0.001). rs3045 and rs875525, two other SNPs in ANKH, associated with CC; aORGENOTYPE (95% CI) values were 1.31 (1.09-1.58) (P = 0.005) and 1.18 (1.03-1.35) (P = 0.015), respectively; however, this was non-significant after Bonferroni correction.
Conclusions: This study validates the association between a functional polymorphism in the 5′ UTR of ANKH and CC and shows for the first time that this is independent of age and OA – the two key risk factors for CC. It shows that other SNPs in ANKH may also associate with CC. This supports the role of extracellular inorganic pyrophosphate in the pathogenesis of CC. The findings of this hospital-based study require replication in a community-based population.
| Item Type: | Journal Article | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > RC Internal medicine | ||||||||||||
| Divisions: | Faculty of Medicine > Warwick Medical School > Health Sciences Faculty of Medicine > Warwick Medical School |
||||||||||||
| Library of Congress Subject Headings (LCSH): | Chondrocalcinosis -- Genetic aspects | ||||||||||||
| Journal or Publication Title: | Arthritis Research & Therapy | ||||||||||||
| Publisher: | BioMed Central Ltd. | ||||||||||||
| ISSN: | 1478-6354 | ||||||||||||
| Official Date: | 27 January 2014 | ||||||||||||
| Dates: |
|
||||||||||||
| Volume: | 16 | ||||||||||||
| Number: | 1 | ||||||||||||
| Number of Pages: | 7 | ||||||||||||
| Article Number: | R25 | ||||||||||||
| DOI: | 10.1186/ar4453 | ||||||||||||
| Status: | Peer Reviewed | ||||||||||||
| Publication Status: | Published | ||||||||||||
| Access rights to Published version: | Open Access | ||||||||||||
| Funder: | AstraZeneca (Firm), Arthritis Research UK, Seventh Framework Programme (European Commission) (FP7) | ||||||||||||
| Grant number: | 14581 (ARUK), 200800 TREAT-OA (FP7) | ||||||||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
